CAMRYN STOVALL: Open Payments
NPI 1770152456 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461 in 28 payments from 11 companies in 2025. Trend: 2023 $503 · 2024 $468 · 2025 $461
Food & beverage: $461
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $219 |
| Lilly USA, LLC | 3 | $53 |
| Madrigal Pharmaceuticals | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Astellas Pharma US Inc | 1 | $24 |
| ABBVIE INC. | 1 | $23 |
| Eisai Inc. | 1 | $17 |
| SANOFI PASTEUR INC. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: PREVNAR 20, NURTEC ODT, MOUNJARO, REZDIFFRA, AIRSUPRA, Veozah, QULIPTA, Leqembi.
Industry payments across OK — which companies pay providers there.
